Structure Therapeutics Inc ADR (NASDAQ: GPCR) on Monday, plunged -3.40% from the previous trading day, before settling in for the closing price of $41.14. Within the past 52 weeks, GPCR’s price has moved between $26.61 and $74.21.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company achieved an average annual earnings per share of 5.40%. With a float of $54.78 million, this company’s outstanding shares have now reached $57.20 million.
In an organization with 93 employees, it is important to assess its efficiency. In terms of profitability, gross margin is -14.48%, operating margin of -9221.68%, and the pretax margin is -7549.14%.
Structure Therapeutics Inc ADR (GPCR) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Structure Therapeutics Inc ADR is 4.22%, while institutional ownership is 99.77%.
Structure Therapeutics Inc ADR (GPCR) Latest Financial update
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.62 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.29) by -0.33. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.21 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 5.40% per share during the next fiscal year.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Trading Performance Indicators
Structure Therapeutics Inc ADR (GPCR) is currently performing well based on its current performance indicators. A quick ratio of 41.38 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.24, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.76 in one year’s time.
Technical Analysis of Structure Therapeutics Inc ADR (GPCR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.83 million. That was better than the volume of 0.78 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 68.50%. Additionally, its Average True Range was 2.41.
During the past 100 days, Structure Therapeutics Inc ADR’s (GPCR) raw stochastic average was set at 34.34%, which indicates a significant decrease from 56.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 56.20% in the past 14 days, which was lower than the 62.47% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $39.60, while its 200-day Moving Average is $40.28. However, in the short run, Structure Therapeutics Inc ADR’s stock first resistance to watch stands at $41.51. Second resistance stands at $43.27. The third major resistance level sits at $44.33. If the price goes on to break the first support level at $38.69, it is likely to go to the next support level at $37.63. The third support level lies at $35.87 if the price breaches the second support level.
Structure Therapeutics Inc ADR (NASDAQ: GPCR) Key Stats
Market capitalization of the company is 2.27 billion based on 57,197K outstanding shares. Right now, sales total 0 K and income totals -89,620 K. The company made 0 K in profit during its latest quarter, and -26,030 K in sales during its previous quarter.
